Ryman Healthcare enjoyed its best week in almost two years.
Stuart Bilbrough tasked with leading the next stage for the supplement-turned-aged care provider.
ANALYSIS: How impact investing can differ depending on the assets.
Helico is designing plants to manufacture life-saving medicines.
First major customer speaks out as DGL shares tumble.
The $57m deal will add 153 units to its portfolio.
UPDATE: DGL issues regretful, but inaccurate, statement on 'unacceptable' comments.
DGL share price down nearly 10% in Australia.
Construction works could begin as early as next year.
Manager sees responsibility to engage with company following Simon Henry’s comments.
